Essent Group Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Sentiment SRRK Q1 2026 Earnings WiderthanExpected Loss Amid Clinical Progress LUCY Q1 2026 Earnings EPS Surprises with a 2282 Beat Despite Missing Revenue Details GLRE Q1 2026 Earnings Strong Profitability Drives Positive Market Response Akebia Therapeutics AKBA Q1 2026 Earnings EPS Misses Estimates Amidst Flat Stock Reaction JUNS Q4 2025 Earnings NarrowerThanExpected Loss Reflects Cost Control Efforts Despite No Revenue